Crinetics gets EMA approval for paltusotine marketing authorization application
Crinetics (CRNX) announced that the European Medicines Agency has validated the marketing authorization application for paltusotine, the first ...
Yahoo Finance5d
ILM-Blue from DORC Receives NMPA Approval in China; Expanding Global Reach
JENA, Germany, March 27, 2025 /PRNewswire/ -- ZEISS Medical Technology announced today that the ILM staining dye ILM-Blue ® from DORC ... Administration (NMPA) approval in China, marking a ...
Pharmabiz3d
DORC’s ILM-Blue receives China NMPA approval; expanding global reach to prove high-quality and effective solutions to ophthalmic community
ZEISS Medical Technology announced that the ILM staining dye ILM-Blue from DORC (Dutch Ophthalmic Research Center (International) B.V.) has received National Medical Products Administration (NMPA) ...
manilatimes5d
ILM-Blue from DORC Receives NMPA Approval in China; Expanding Global Reach
"We are delighted to bring ILM-Blue to the Chinese market, where it will provide retina surgeons with a proven, high-quality staining solution to enhance visualization," says Jessie Jiang Bo, General ...
pharmaphorum5d
EMA recommends Novartis' meningitis B vaccine for approval
The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended Novartis’ meningitis B vaccine, Bexsero, for approval for use in patients aged 2 months or older.
Finanznachrichten5d
Carl Zeiss Meditec AG: ILM-Blue from DORC Receives NMPA Approval in China; Expanding Global Reach
"This approval reinforces our dedication to expanding access to innovative ophthalmic solutions that help surgeons to improve patient outcomes." ILM-Blue ® is used to clearly stain and easily ...
pharmaphorum4d
Vertex gets EU okay to treat younger cystic fibrosis patients
A new EMA approval has expanded the use of Vertex Pharma’s cystic fibrosis therapy Symkevi to children as young as six if they have specific gene mutations. The regulator has given a green light ...